Blood tests measuring PFAS can help doctors manage risks for patients who have been significantly exposed to the chemicals—but the tests cost up to $600, and insurance generally doesn’t cover them.
“Patients with high levels of PFAS, have a higher risk of certain diseases,” including increased cholesterol and certain cancers, said Rachel Criswell, a primary care physician with Redington-Fairview General Hospital in Skowhegan, Maine.
Yet some of her patients decline PFAS tests, she said. “They can’t afford them.”
Two states—New Hampshire and Maine—have led US efforts to mandate insurance coverage.
New Hampshire approved legislation in 2020. ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.